A US Food and Drug Administration (FDA) investigation of injection-site necrosis in some people who received the 23-valent pneumococcal vaccine has concluded that the benefits of the vaccine outweigh ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback